Biomarkers

Discover all biomarkers in precision medicine

Loading biomarkers...

Results for "Insulin"

Target: Insulin

Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver

Clinical Applications

Diabetes Mellitus Type 1Normal

uniprot

Approved Therapies

Octreotide Acetate (OCTREOTIDE ACETATE) ^[5]

Status: approved

APPROVED

Ciclopirox (CICLOPIROX) ^[6]

Status: approved

APPROVED

PIOGLITAZONE HYDROCHLORIDE (PIOGLITAZONE HYDROCHLORIDE) ^[7]

Status: approved

APPROVED

Pioglitazone (PIOGLITAZONE) ^[8]

Status: approved

APPROVED

Pipeline Therapies

The MULTISITE Study

Aalborg University Hospital

Siplizumab in T1DM

National Institute of Allergy and Infectious Diseases (NIAID)

PHASE1, PHASE2

The Effect of Locally Dilvered Ciprofloxacine Loaded Injectable Platelet-rich Fibrin as an Adjunct to Non-surgical Periodontal Therapy on the Gingival Crevicular Level of Interleukin 6

Suez Canal University

Prevention of the Metabolic Syndrome by New Lifestyle Intervention Methods

University of Oulu

Comparison of Low, Moderate and High Carbohydrate Diet on Insulin Requirements and Metabolic Control in Type 1 Diabetes

Karolinska Institutet

Companies Working on Insulin

Aalborg University Hospital

NAFLD

National Institute of Allergy and Infectious Diseases (NIAID)

Type 1 Diabetes Mellitus

Suez Canal University

Periodontitis Stage II

Ciprofloxacin

University of Oulu

Metabolic Syndrome

TrialsMap

Clinical Intelligence Agent

Interactive Clinical Trials Map

1294

United States

1271

Europe

619

Asia

418

Other

LitSearch

Scientific Literature Agent

Scientific Publications

Recent Advances in Insulin Therapy.

PubMedDec 2020

New classification and diagnostic criteria for insulin resistance syndrome.

PubMedFeb 2022

The impact of insulin resistance on the kidney and vasculature.

PubMedDec 2016

Insulin dysregulation.

PubMedJan 2014

Research Insights

Publication count:

4 papers

Research focus:

Diabetes Mellitus Type 1

Sources & References

Recent Advances in Insulin Therapy.

PubMed•Dec 2020

New classification and diagnostic criteria for insulin resistance syndrome.

PubMed•Feb 2022

The impact of insulin resistance on the kidney and vasculature.

PubMed•Dec 2016

Insulin dysregulation.

PubMed•Jan 2014

Insulin - Biomarker

Biomarkers

Results for "Insulin"

Target: Insulin

Clinical Applications

Approved Therapies

Octreotide Acetate (OCTREOTIDE ACETATE) [5]

Ciclopirox (CICLOPIROX) [6]

PIOGLITAZONE HYDROCHLORIDE (PIOGLITAZONE HYDROCHLORIDE) [7]

Pioglitazone (PIOGLITAZONE) [8]

Pipeline Therapies

The MULTISITE Study

Siplizumab in T1DM

The Effect of Locally Dilvered Ciprofloxacine Loaded Injectable Platelet-rich Fibrin as an Adjunct to Non-surgical Periodontal Therapy on the Gingival Crevicular Level of Interleukin 6

Prevention of the Metabolic Syndrome by New Lifestyle Intervention Methods

Comparison of Low, Moderate and High Carbohydrate Diet on Insulin Requirements and Metabolic Control in Type 1 Diabetes

Companies Working on Insulin

Aalborg University Hospital

National Institute of Allergy and Infectious Diseases (NIAID)

Suez Canal University

University of Oulu

TrialsMap

Interactive Clinical Trials Map

LitSearch

Scientific Publications

Recent Advances in Insulin Therapy.

New classification and diagnostic criteria for insulin resistance syndrome.

The impact of insulin resistance on the kidney and vasculature.

Insulin dysregulation.

Research Insights

Sources & References

Octreotide Acetate (OCTREOTIDE ACETATE) ^[5]

Ciclopirox (CICLOPIROX) ^[6]

PIOGLITAZONE HYDROCHLORIDE (PIOGLITAZONE HYDROCHLORIDE) ^[7]

Pioglitazone (PIOGLITAZONE) ^[8]